← Back to Search

Laser Therapy

Hybrid Fractional Laser for Acne Scars

N/A
Recruiting
Led By Kseniya Kobets, MD
Research Sponsored by Albert Einstein College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for acne scarring
Subjects with diagnosis of acne scarring recorded over the past 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 8
Awards & highlights

Study Summary

This trial looks at how well a laser treatment works to reduce acne scars on skin of color.

Who is the study for?
This trial is for adults over 18 with a history of acne scarring who are seeking treatment. Participants must be healthy, non-smokers, and able to follow the study's procedures. They cannot have had any facial surgery in the past year or acne scar treatments in the last six months, nor should they have certain health conditions like major depression, endocrine disorders, or a tendency to form keloid scars.Check my eligibility
What is being tested?
The Sciton Halo laser is being tested for its effectiveness on treating acne scars specifically in people with skin of color. The study will assess how well it works and how tolerable it is for participants.See study design
What are the potential side effects?
Potential side effects may include temporary redness, swelling at the treatment site, changes in skin pigmentation such as lightening or darkening of treated areas (hyperpigmentation), and possibly some discomfort during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and want treatment for my acne scars.
Select...
I have been diagnosed with acne scarring in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Baseline Patient Satisfaction
Cicatrization
Dermatology Quality of Life Survey
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Hybrid Fractional laser- Non- SOCExperimental Treatment1 Intervention
23 participants with Fitzpatrick skin type I-III will be in this arm. At the first visit, participants will undergo informed consent, education about the procedure, education about proper sun-care, and will be provided sunscreen. Participants will be prescribed a prescription of hydroquinone or a retinol to prevent hyperpigmentation, per standard of care. If participants choose to take this they will wait one month of taking the prescription and then begin treatment sessions. If not, participants can begin treatment sessions right away. Treatment consists of 3 laser sessions with the Sciton Halo hybrid fractional laser. Session amount depends on the degree of improvement. At each session before and after images will be collected. At each session participants will fill out the dermatology quality of life survey as well as a patient satisfaction survey.
Group II: Hybrid Fractional laser - SOCExperimental Treatment1 Intervention
23 participants with fitzpatrick skin type IV-V will be in this arm. At the first visit, participants will undergo informed consent, education about the procedure, education about proper sun-care, and will be provided sunscreen. Participants will be prescribed a prescription of hydroquinone or a retinol to prevent hyperpigmentation, per standard of care. If participants choose to take this they will wait one month of taking the prescription and then begin treatment sessions. If not, participants can begin treatment sessions right away. Treatment consists of 3 laser sessions with the Sciton Halo hybrid fractional laser. Session amount depends on the degree of improvement. At each session before and after images will be collected. At each session participants will fill out the dermatology quality of life survey as well as a patient satisfaction survey.

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor
287 Previous Clinical Trials
11,856,790 Total Patients Enrolled
Kseniya Kobets, MDPrincipal InvestigatorMontefiore Medical Center
4 Previous Clinical Trials
29 Total Patients Enrolled

Media Library

Sciton Halo (Laser Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05362929 — N/A
Hyperpigmentation Research Study Groups: Hybrid Fractional laser - SOC, Hybrid Fractional laser- Non- SOC
Hyperpigmentation Clinical Trial 2023: Sciton Halo Highlights & Side Effects. Trial Name: NCT05362929 — N/A
Sciton Halo (Laser Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05362929 — N/A
~29 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top